These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22658279)

  • 21. Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.
    Wuchter P; Ran D; Bruckner T; Schmitt T; Witzens-Harig M; Neben K; Goldschmidt H; Ho AD
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):490-9. PubMed ID: 19925876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells.
    Hart C; Grassinger J; Andreesen R; Hennemann B
    Bone Marrow Transplant; 2009 Feb; 43(3):197-206. PubMed ID: 18806833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection.
    Corso A; Varettoni M; Mangiacavalli S; Zappasodi P; Klersy C; Rusconi C; Colucci E; Lorenzi A; Troletti D; Consensi E; Lazzarino M
    Leuk Res; 2005 Feb; 29(2):159-63. PubMed ID: 15607364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies.
    Bolwell BJ; Pohlman B; Rybicki L; Sobecks R; Dean R; Curtis J; Andresen S; Koo A; Mineff V; Kalaycio M; Sweetenham JW
    Bone Marrow Transplant; 2007 Sep; 40(5):437-41. PubMed ID: 17618321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobilization of peripheral blood progenitor cells with G-CSF alone in lymphoma patients: steady-state circulating progenitor cell count predicts the autograft yield.
    Grimaz S; Damiani D; Michieli M; Baccarani M
    Haematologica; 2000 Jan; 85(1):102-3. PubMed ID: 10629603
    [No Abstract]   [Full Text] [Related]  

  • 26. Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
    Tomblyn M; Burns LJ; Blazar B; Wagner J; Lee C; Rogers T; McGlave P; Miller JS; Weisdorf DJ
    Bone Marrow Transplant; 2007 Jul; 40(2):111-8. PubMed ID: 17530003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appropriate timing of G-CSF use after mobilization chemotherapy significantly increases the yield of CD34+ cells in autoPBSCT.
    Xu L; Chang C; Li X; Gan W
    J Clin Apher; 2009; 24(6):232-7. PubMed ID: 19899124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
    Hicks C; Isaacs A; Wong R; Chong BH
    Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
    Viola A; Falco C; D'Elia R; D'Amico MR; Vicari L; Tambaro FP; Correale P; Laudati D; Palmieri S; Ferrara F
    Eur J Haematol; 2007 Jan; 78(1):41-7. PubMed ID: 17042770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis.
    Rinn JP; Schwella N; Wollmer E; Jaques G; Heinzel-Gutenbrunner M; Strassmann G; Gross MW; Movassaghi K; Neubauer A; Ritter M
    Ann Hematol; 2006 Jan; 85(1):38-44. PubMed ID: 16012838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Kroschinsky F; Hölig K; Platzbecker U; Poppe-Thiede K; Ordemann R; Blechschmidt M; Oelschlaegel U; Schaich M; Hänel M; Bornhäuser M; Ehninger G
    Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis.
    Locatelli F; Perotti C; Torretta L; Maccario R; Montagna D; Ravelli A; Giorgiani G; De Benedetti F; Giraldi E; Magnani ML; De Stefano P; Martini A
    Haematologica; 1999 Sep; 84(9):839-43. PubMed ID: 10477459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sepsis, low platelet nadir at mobilization and previous IFN use predict stem cell mobilization failure in patients with multiple myeloma.
    Putkonen M; Rauhala A; Pelliniemi TT; Remes K
    Cytotherapy; 2007; 9(6):548-54. PubMed ID: 17882719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
    Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
    Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].
    Qiu HY; Wu DP; Sun AN; Chang WR; Jin ZM; Miao M; Tang XW; Shen YM; Fu ZZ
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):462-5. PubMed ID: 15555260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
    Annunziata M; Celentano M; Pocali B; D'Amico MR; Palmieri S; Viola A; Copia C; Falco C; Del Vecchio L; Ferrara F
    Ann Hematol; 2006 Jun; 85(6):394-9. PubMed ID: 16538502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
    Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
    Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.